Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Effect of interferon gamma on sepsis-related death in patients with immunoparalysis

Impaired host defense mechanisms following surgical stress such as burn, major surgery and polytrauma are considered important for the development of infectious complications and sepsis. We tested whether interferon (IFN) gamma can improve monocytic and lymphocytic functions and can reduce deaths related to sepsis. In order to restore their antimicrobial defense capacity, recombinant human IFN-gamma, 100 μg, was administered intravenously once daily to six immunoparalyzed patients. Informed consent was obtained from patients in all cases, and the study received local hospital ethical committee approval. Intracytoplasmic Th1 and Th2 cytokine production in isolated peripheral blood mononuclear cells was assessed by flow cytometry following in vitro activation by phorbol myristate acetate plus ionomycin. Monocytic human leukocyte antigen-DR (HLA-DR) expression was also measured. Immunoparalysis was defined as a decreased level of HLA-DR expression of monocytes <30% or a decreased level of Th1 <10%. IFN-gamma applied to immunoparalytic patients with low monocytic HLA-DR expression restored the deficient HLA-DR expression and in vitro Th1 cytokine production completely within 3 days. Recovery from immunoparalysis resulted in clearance of sepsis in four of six patients. IFN-gamma administration in septic patients accompanied with immunoparalysis is a new therapeutic strategy.

Table 1 Table 1

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Takeyama, N., Tanaka, T., Yabuki, T. et al. Effect of interferon gamma on sepsis-related death in patients with immunoparalysis. Crit Care 8, P207 (2004). https://doi.org/10.1186/cc2674

Download citation

Keywords

  • Phorbol
  • Interferon Gamma
  • Myristate
  • Ionomycin
  • Myristate Acetate